FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3190746189> ?p ?o ?g. }

• W3190746189 endingPage "40" @default.
• W3190746189 startingPage "335" @default.
• W3190746189 abstract "This study was aimed at examining major cytogenetic response (MCR) as a valid predictor of the course of chronic myeloid leukemia (CML) and at assessing the survival of CML patients treated with interferon alpha (IFN) in dependence on the combination of MCR (yes or no) with the baseline risk group of the New CML score. MCR was defined as a reduction of Philadelphia chromosome-positive bone marrow cells to <or= 35%. The New CML score discriminated three risk groups with significantly different survival probabilities.Data from individual patients with a confirmed diagnosis of Philadelphia chromosome-positive CML treated with IFN were collected from 10 prospective studies in Europe and Japan. Stratified for baseline risk group, patients with a major cytogenetic response by 21 months after the start of therapy (n=171) were compared with patients achieving a minor response or less (n=487). Survival probabilities after the landmark at 21 months were compared by using the two-sided log-rank test.MCR was a major predictor for low- and intermediate-risk patients (log-rank test, p <or= 0.0001), but not for high-risk patients. Ten-year survival probabilities for the low- and intermediate-risk patients who had a MCR were 75% (95 CI: 65-86%) and 56% (95 CI: 37-75%), respectively. The corresponding probabilities for patients who did not achieve a MCR were 21% (95 CI: 6-35%) and 16% (95 CI: 6-25%).Cytogenetic response per se is not a valid surrogate marker, as it is dependent on the baseline prognostic profile. The combination of risk group and cytogenetic response does, however, provide useful clinical information. The survival data presented here can serve as a benchmark for the assessment of the long-term effectiveness of imatinib." @default.
• W3190746189 created "2021-08-16" @default.
• W3190746189 creator A5001222821 @default.
• W3190746189 creator A5016147985 @default.
• W3190746189 creator A5038000746 @default.
• W3190746189 creator A5039285562 @default.
• W3190746189 creator A5039801586 @default.
• W3190746189 creator A5061475875 @default.
• W3190746189 creator A5066994665 @default.
• W3190746189 creator A5075844368 @default.
• W3190746189 creator A5079181777 @default.
• W3190746189 creator A5086462994 @default.
• W3190746189 date "2005-03-01" @default.
• W3190746189 modified "2023-09-26" @default.
• W3190746189 title "The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha." @default.
• W3190746189 cites W2006348547 @default.
• W3190746189 cites W2011474502 @default.
• W3190746189 cites W2011672574 @default.
• W3190746189 cites W2018734495 @default.
• W3190746189 cites W2028959752 @default.
• W3190746189 cites W2038990138 @default.
• W3190746189 cites W2039045990 @default.
• W3190746189 cites W2053742345 @default.
• W3190746189 cites W2076736727 @default.
• W3190746189 cites W2079517811 @default.
• W3190746189 cites W2117806883 @default.
• W3190746189 cites W2120079339 @default.
• W3190746189 cites W2120756704 @default.
• W3190746189 cites W2128738046 @default.
• W3190746189 cites W2157743993 @default.
• W3190746189 cites W2171722798 @default.
• W3190746189 cites W2776340694 @default.
• W3190746189 cites W3026292011 @default.
• W3190746189 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15749665" @default.
• W3190746189 hasPublicationYear "2005" @default.
• W3190746189 type Work @default.
• W3190746189 sameAs 3190746189 @default.
• W3190746189 citedByCount "7" @default.
• W3190746189 countsByYear W31907461892015 @default.
• W3190746189 countsByYear W31907461892016 @default.
• W3190746189 crossrefType "journal-article" @default.
• W3190746189 hasAuthorship W3190746189A5001222821 @default.
• W3190746189 hasAuthorship W3190746189A5016147985 @default.
• W3190746189 hasAuthorship W3190746189A5038000746 @default.
• W3190746189 hasAuthorship W3190746189A5039285562 @default.
• W3190746189 hasAuthorship W3190746189A5039801586 @default.
• W3190746189 hasAuthorship W3190746189A5061475875 @default.
• W3190746189 hasAuthorship W3190746189A5066994665 @default.
• W3190746189 hasAuthorship W3190746189A5075844368 @default.
• W3190746189 hasAuthorship W3190746189A5079181777 @default.
• W3190746189 hasAuthorship W3190746189A5086462994 @default.
• W3190746189 hasConcept C104317684 @default.
• W3190746189 hasConcept C126322002 @default.
• W3190746189 hasConcept C138626823 @default.
• W3190746189 hasConcept C143998085 @default.
• W3190746189 hasConcept C174475383 @default.
• W3190746189 hasConcept C188816634 @default.
• W3190746189 hasConcept C203014093 @default.
• W3190746189 hasConcept C2776178377 @default.
• W3190746189 hasConcept C2778729363 @default.
• W3190746189 hasConcept C2778904597 @default.
• W3190746189 hasConcept C2909179924 @default.
• W3190746189 hasConcept C30481170 @default.
• W3190746189 hasConcept C54355233 @default.
• W3190746189 hasConcept C71924100 @default.
• W3190746189 hasConcept C86803240 @default.
• W3190746189 hasConcept C90924648 @default.
• W3190746189 hasConceptScore W3190746189C104317684 @default.
• W3190746189 hasConceptScore W3190746189C126322002 @default.
• W3190746189 hasConceptScore W3190746189C138626823 @default.
• W3190746189 hasConceptScore W3190746189C143998085 @default.
• W3190746189 hasConceptScore W3190746189C174475383 @default.
• W3190746189 hasConceptScore W3190746189C188816634 @default.
• W3190746189 hasConceptScore W3190746189C203014093 @default.
• W3190746189 hasConceptScore W3190746189C2776178377 @default.
• W3190746189 hasConceptScore W3190746189C2778729363 @default.
• W3190746189 hasConceptScore W3190746189C2778904597 @default.
• W3190746189 hasConceptScore W3190746189C2909179924 @default.
• W3190746189 hasConceptScore W3190746189C30481170 @default.
• W3190746189 hasConceptScore W3190746189C54355233 @default.
• W3190746189 hasConceptScore W3190746189C71924100 @default.
• W3190746189 hasConceptScore W3190746189C86803240 @default.
• W3190746189 hasConceptScore W3190746189C90924648 @default.
• W3190746189 hasIssue "3" @default.
• W3190746189 hasLocation W31907461891 @default.
• W3190746189 hasOpenAccess W3190746189 @default.
• W3190746189 hasPrimaryLocation W31907461891 @default.
• W3190746189 hasRelatedWork W1997991070 @default.
• W3190746189 hasRelatedWork W2056196369 @default.
• W3190746189 hasRelatedWork W2307412595 @default.
• W3190746189 hasRelatedWork W2405948446 @default.
• W3190746189 hasRelatedWork W2408020729 @default.
• W3190746189 hasRelatedWork W2434975303 @default.
• W3190746189 hasRelatedWork W2462392570 @default.
• W3190746189 hasRelatedWork W2742933893 @default.
• W3190746189 hasRelatedWork W3190746189 @default.
• W3190746189 hasRelatedWork W172737148 @default.
• W3190746189 hasVolume "90" @default.

• next